Lakefront Biotherapeutics Stock: price and insider trades · Belgium

This page follows insider dealings at Lakefront Biotherapeutics as filed with FSMA based in Mechelen, Belgium. The group dates from 1999. 7 insiders have disclosed 14 filings since 18 October 2025.

The flow runs one way only: 7 insiders bought (14 purchases totalling €542k) and nobody sold on the market. The totals exclude 7 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 7 board members. At €236k, the purchase published on 11 May 2026 by Cox Aaron is the largest of the period.

Compared with its exchange (77 companies, median 10 filings), a count of 14 filings is above the norm. Over the whole record (from 2025), the tally stands at 50 purchases and no sales.

In all, 6 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 12 May 2026, 159 days ago. Between a trade and the moment it shows up on FSMA, the median delay is 26 days. The regulation allows three business days to notify a trade (MAR article 19).

Every figure here comes from the filings published by FSMA and describes the past, not future prices; it is not investment advice.